Comparative colloidal stability, antitumor efficacy, and immunosuppressive effect of commercial paclitaxel nanoformulations

Comparative colloidal stability, antitumor efficacy, and immunosuppressive effect of commercial paclitaxel nanoformulations

Abstract Background Standard chemotherapy with taxanes, such as paclitaxel (PTX), remains the mainstay of systemic treatment of triple-negative breast cancer. Nanotechnology-based formulations have gradually replaced PTX injection and are widely used in China. However, no studies have compared the c...

Full description

Bibliographic Details
Main Authors: Jun Ye, Renjie Li, Yanfang Yang, Wujun Dong, Yujie Wang, Hongliang Wang, Tong Sun, Lin Li, Qiqi Shen, Caiyun Qin, Xiaoyan Xu, Hengfeng Liao, Yiqun Jin, Xuejun Xia, Yuling Liu
Format: Article
Language:English
Published: BMC 2021-07-01
Series:Journal of Nanobiotechnology
Subjects:
Paclitaxel
Nanoparticle
Liposome
Emulsion
Stability
Immunosuppression
Online Access:https://doi.org/10.1186/s12951-021-00946-w

Internet

https://doi.org/10.1186/s12951-021-00946-w

Similar Items